douglas w. blayney, md, discusses the implications of the tailorx study
Published 6 years ago • 58 plays • Length 1:37
Download video MP4
Download video MP3
Similar videos
-
0:28
douglas w. blayney, md, on if the results of the tailorx study practice changing
-
1:01
douglas w. blayney, md, discusses the biggest takeaway regarding breast cancer here at asco 2018
-
0:45
douglas w. blayney, md, discusses the monaleesa-3 study in hr /her2- advanced breast cancer
-
4:04
stanford oncologist, douglas blayney, md, discusses breast cancer
-
1:30
douglas w. blayney, md, on differentiating cdk4/6 inhibitors and if they can be used interchangeably
-
33:23
oncotype dx breast recurrence score assay after tailorx and rxponder: what’s next?
-
1:01:34
er breast cancer case panel discussion | 2022 best of breast conference
-
55:33
personalized medicine: the role of testing in metastatic breast cancer
-
0:16
sara m. tolaney, md, mph, on whether the results of the tailorx study are “practice changing”
-
8:44
dr richard de boer discusses the tailorx trial of oncotypedx
-
5:59
tailorx study explained by a medical oncologist
-
0:37
julie gralow, md, comments on the practice-changing implications of the tailorx study
-
1:48
sara m. tolaney, md, mph discusses the tailorx study
-
2:02
tailorx: patient-reported outcomes in breast cancer
-
5:34
tailorx: phase 3 trial validating a 21-gene expression assay in breast cancer
-
0:57
dr. taylor discusses the toxicities and impact of lenvatinib in the select trial
-
1:01
larry norton on the use of chemotherapy for women with intermediate-risk breast cancer
-
1:50
julie gralow, md, discusses outcomes from the tailorx study presented at asco 2018
-
50:22
treating metastatic breast cancer: the promise of precision medicine
-
0:32
julie gralow, md, on the implications of the persephone trial in early her2 breast cancer
-
5:33
chemotherapy for metastatic breast cancer in 2017
-
15:23
tailorx
Clip.africa.com - Privacy-policy